|
|
||||||||
The Journal of Immunology, Vol 157, Issue 6 2328-2339, Copyright © 1996 by American Association of Immunologists
ARTICLES |
S Kitagawa-Sakakida and RH Schwartz
Laboratory of Cellular and Molecular Immunology, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.
The molecular mechanism underlying IL-2 transcriptional blockade in anergic T cell clones is not fully understood. To examine whether an active negative regulatory process occurs, we created a reporter construct containing as an enhancer four copies of the NF-AT site and one copy of the octamer site (4X NF-AT-Oct). This construct was only slightly reduced (1.3-fold) in its expression when stimulated under anergic conditions, while a whole mouse IL-2 enhancer construct showed a reduction of 4.3-fold. Addition of the -176 to -96 sequence to the 4X NF-AT-Oct construct did not impart the ability to be affected by anergy, but addition of the -236 to -96 sequence did, demonstrating that anergy is an active inhibitory process and that more than the presence of the -150 AP-1 binding site (-152 to -147) is required to mediate the effect. Mutational studies of the -236 to -96 sequence indicated that the presence of both the -130 AP-1-like site (-187 to - 181) and the -150 proximal AP-1 site were necessary to observe anergy. Because the -180 site is not required for trans-activation, it was possible to confirm by mutation in the normal mouse IL-2 enhancer that this site is absolutely essential for anergy induction. The simplest model to explain these results is that anergy is mediated by a complex of multiple transcription factors that exert a cis-acting dominant negative regulatory effect on the trans-activation of the IL-2 gene.
This article has been cited by other articles:
![]() |
S.-M. Lee, B. Gao, and D. Fang FoxP3 maintains Treg unresponsiveness by selectively inhibiting the promoter DNA-binding activity of AP-1 Blood, April 1, 2008; 111(7): 3599 - 3606. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Thomas, N. Chunder, C. Chen, S. E. Umetsu, S. Winandy, and A. D. Wells Ikaros Enforces the Costimulatory Requirement for IL2 Gene Expression and Is Required for Anergy Induction in CD4+ T Lymphocytes J. Immunol., December 1, 2007; 179(11): 7305 - 7315. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bostik, E. S. Noble, S. T. Stephenson, F. Villinger, and A. A. Ansari CD4+ T Cells from Simian Immunodeficiency Virus Disease-Resistant Sooty Mangabeys Produce More IL-2 Than Cells from Disease-Susceptible Species: Involvement of p300 and CREB at the Proximal IL-2 Promoter in IL-2 Up-Regulation J. Immunol., June 15, 2007; 178(12): 7720 - 7729. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Dillon, V. Karpitski, S. A. Wetzel, D. C. Parker, A. S. Shaw, and P. J. S. Stork Ectopic B-Raf Expression Enhances Extracellular Signal-regulated Kinase (ERK) Signaling in T Cells and Prevents Antigen-presenting Cell-induced Anergy J. Biol. Chem., September 19, 2003; 278(38): 35940 - 35949. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Abraham and J. Miller Molecular Mechanisms of IL-2 Gene Regulation Following Costimulation Through LFA-1 J. Immunol., November 1, 2001; 167(9): 5193 - 5201. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Finch, P. E. Fields, and P. D. Greenberg A Transcriptional Block in the IL-2 Promoter at the -150 AP-1 Site in Effector CD8+ T Cells J. Immunol., June 1, 2001; 166(11): 6530 - 6536. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bostik, A. E. Mayne, F. Villinger, K. P. Greenberg, J. D. Powell, and A. A. Ansari Relative Resistance in the Development of T Cell Anergy in CD4+ T Cells from Simian Immunodeficiency Virus Disease-Resistant Sooty Mangabeys J. Immunol., January 1, 2001; 166(1): 506 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Attinger, H. Acha-Orbea, and H. R. MacDonald Cutting Edge: Cell Autonomous Rather Than Environmental Factors Control Bacterial Superantigen-Induced T Cell Anergy In Vivo J. Immunol., August 1, 2000; 165(3): 1171 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iacobelli, W. Wachsman, and K. L. McGuire Repression of IL-2 Promoter Activity by the Novel Basic Leucine Zipper p21SNFT Protein J. Immunol., July 15, 2000; 165(2): 860 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Lerner, M. R. Horton, R. H. Schwartz, and J. D. Powell Distinct Requirements for C-C Chemokine and IL-2 Production by Naive, Previously Activated, and Anergic T Cells J. Immunol., April 15, 2000; 164(8): 3996 - 4002. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Korthauer, W. Nagel, E. M. Davis, M. M. Le Beau, R. S. Menon, E. O. Mitchell, C. A. Kozak, W. Kolanus, and J. A. Bluestone Anergic T Lymphocytes Selectively Express an Integrin Regulatory Protein of the Cytohesin Family J. Immunol., January 1, 2000; 164(1): 308 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Powell, C. G. Lerner, G. R. Ewoldt, and R. H. Schwartz The -180 Site of the IL-2 Promoter Is the Target of CREB/CREM Binding in T Cell Anergy J. Immunol., December 15, 1999; 163(12): 6631 - 6639. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. GUDMUNDSDOTTIR and L. A. TURKA T Cell Costimulatory Blockade: New Therapies for TransplantRejection J. Am. Soc. Nephrol., June 1, 1999; 10(6): 1356 - 1365. [Abstract] [Full Text] |
||||
![]() |
J. D. Powell, C. G. Lerner, and R. H. Schwartz Inhibition of Cell Cycle Progression by Rapamycin Induces T Cell Clonal Anergy Even in the Presence of Costimulation J. Immunol., March 1, 1999; 162(5): 2775 - 2784. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bonnard, L. Haughn, and M. Julius CD4-Mediated Inhibiton of IL-2 Production in Activated T Cells J. Immunol., February 1, 1999; 162(3): 1252 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Telander, E.-N. Malvey, and D. L. Mueller Evidence for Repression of IL-2 Gene Activation in Anergic T Cells J. Immunol., February 1, 1999; 162(3): 1460 - 1465. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gonsky, R. L. Deem, C. C. W. Hughes, and S. R. Targan Activation of the CD2 Pathway in Lamina Propria T Cells Up-Regulates Functionally Active AP-1 Binding to the IL-2 Promoter, Resulting in Messenger RNA Transcription and IL-2 Secretion J. Immunol., May 15, 1998; 160(10): 4914 - 4922. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |